Currently Observed Trend in the Resistance of Malaria to Artemisinin Based Combination Therapy in Nigeria – A Report of 5 Cases

Journal Title: International Journal of TROPICAL DISEASE & Health - Year 2017, Vol 21, Issue 2

Abstract

Malaria is a life threatening disease caused by parasites transmitted through the bite of an infected female mosquito. About 3.2 million (about half of the world’s population) are at risk of malaria; it affects all age group from young to old. Between 2002 – 2015, Sub-Saharan Africa was home to 88% of malaria cases and 90% of malaria deaths most of which were under-five years old. Plasmodium falciparum – transmitted by female Anopleles mosquito (one of the five parasites that cause malaria in humans) is the most prevalent malaria parasite in the African continent and is responsible for most malaria-related deaths globally [1]. Artemisinin-based combination therapy (ACT) resistance is rare in Sub-Saharan Africa. The World Health Organization (WHO) identifies monitoring and surveillance using day – 3 parasitaemia post treatment as the standard test for identifying suspected artemisinin resistance [2]. Early treatment failure due to possible ACT resistant Plasmodium falciparum has been identified in 5 cases across different age group, race, sex and gender. All cases managed showed significant clinical and parasitological responses to further treatment with combined Artesunate (intravenous) and Arthemeter (intramuscular), Arthemeter only (IM) or Artesunate tablets. This study seeks to emphasize the need for a re-evaluation of the malaria treatment protocol and to throw more light on the increasing resistance of Plasmodium falciparum to the commonly used Artemisinin – based combination therapy agents in Nigeria.

Authors and Affiliations

Gonen S. Wundermann, Agbonmeire Awele Osiki

Keywords

Related Articles

P53 Codon 72 Polymorphism and the Risk of Cervical Cancer in Zimbabwean Women

Aims: To investigate the prevalence of p53 codon 72 polymorphism in Zimbabwean women and risk of cervical cancer Study Design: Case-control study Place and Duration of Study: Parirenyatwa Referral Hospital in Harare in b...

Spatial Modelling of Fever Prevalence and Suspected Malaria Cases among Children: A Cross-sectional Study

Background: Disease morbidity, mortality and speed of spread vary substantially spatially. These have important implications for effective planning and targeting intervention strategies. The purpose of this study was to...

Filarial Elimination in India Missing Its Deadline– Evidence from a Cross Sectional Study of Four Districts of Uttar Pradesh

Objective: India in its national health policy-2002 proposed to eliminate filaria from India by 2015. For this India started Maas Drug Administration in year 2004. Since then few states has already achieved zero micro fi...

Effects of Emergency Injury Care (EIC) Training for the Community Volunteers in the Rural Community of Bangladesh

Background: Injury is the leading causes of morbidity and mortality including disability worldwide. Emergency Injury Care (EIC) is provided to stabilize casualties with life-threatening injury in an emergency situation b...

Correlation of Microalbumin with Biochemical and Anthropometric Parameters in Sickle Cell Anaemia Patients in Southern Nigeria

The renal manifestations of sickle cell anaemia (SCA) can range from haematuria and abnormal tubular function to massive proteinuria and end stage renal disease. This study was designed to screen for microalbuminuria in...

Download PDF file
  • EP ID EP310646
  • DOI 10.9734/IJTDH/2017/30914
  • Views 78
  • Downloads 0

How To Cite

Gonen S. Wundermann, Agbonmeire Awele Osiki (2017). Currently Observed Trend in the Resistance of Malaria to Artemisinin Based Combination Therapy in Nigeria – A Report of 5 Cases. International Journal of TROPICAL DISEASE & Health, 21(2), 1-5. https://europub.co.uk/articles/-A-310646